65000EGP
- Active ingredient
- miglustat
- Strength
- 100mg
- Form
- tablet
- Manufacturer
- actelion > johnson & johnson
- Route
- oral.solid
Uses
Used as monotherapy for adults with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not suitable.
Do not use if
No specific contraindications established; avoid use in patients with hypersensitivity to the product.
Side effects
Diarrhea, weight loss, tremor, peripheral neuropathy, and reduced platelet counts may occur.
Warnings
Neurological evaluation and monitoring for tremor, neuropathy, diarrhea, and weight loss are recommended.
How it works
Inhibits glucosylceramide synthase and reduces glycosphingolipid production.
Storage
Store at room temperature in the original container.
